Perrigo Company plc (NYSE:PRGO – Free Report) – Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of Perrigo in a research note issued on Thursday, March 20th. Zacks Research analyst S. Ganoria now forecasts that the company will earn $0.44 per share for the quarter, down from their prior forecast of $0.52. The consensus estimate for Perrigo’s current full-year earnings is $2.56 per share. Zacks Research also issued estimates for Perrigo’s Q2 2025 earnings at $0.70 EPS, Q3 2025 earnings at $0.79 EPS, FY2025 earnings at $2.93 EPS, Q1 2026 earnings at $0.55 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $0.83 EPS, Q4 2026 earnings at $0.99 EPS, FY2026 earnings at $3.20 EPS and FY2027 earnings at $3.51 EPS.
Other equities research analysts also recently issued reports about the stock. Piper Sandler downgraded shares of Perrigo from an “overweight” rating to a “neutral” rating and cut their price target for the company from $34.00 to $27.00 in a report on Monday, January 6th. Argus lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Finally, StockNews.com lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $33.00.
Perrigo Stock Down 1.8 %
Shares of PRGO stock opened at $27.25 on Monday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The stock has a market cap of $3.72 billion, a PE ratio of -23.29 and a beta of 0.48. The business’s fifty day moving average is $25.87 and its 200-day moving average is $26.14. Perrigo has a 1 year low of $23.14 and a 1 year high of $33.46.
Perrigo (NYSE:PRGO – Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.20 billion.
Perrigo Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th were given a dividend of $0.29 per share. The ex-dividend date of this dividend was Friday, March 7th. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. This represents a $1.16 dividend on an annualized basis and a yield of 4.26%. Perrigo’s dividend payout ratio (DPR) is presently -92.80%.
Insider Buying and Selling at Perrigo
In other news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the sale, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. The trade was a 18.81 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.70% of the company’s stock.
Institutional Investors Weigh In On Perrigo
Several institutional investors and hedge funds have recently modified their holdings of PRGO. California State Teachers Retirement System lifted its position in shares of Perrigo by 11.4% in the fourth quarter. California State Teachers Retirement System now owns 145,760 shares of the company’s stock worth $3,747,000 after buying an additional 14,893 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of Perrigo by 9.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 23,149 shares of the company’s stock valued at $595,000 after acquiring an additional 1,968 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Perrigo in the fourth quarter worth $383,000. University of Texas Texas AM Investment Management Co. boosted its holdings in Perrigo by 12.0% during the fourth quarter. University of Texas Texas AM Investment Management Co. now owns 38,424 shares of the company’s stock valued at $988,000 after acquiring an additional 4,105 shares during the period. Finally, Novem Group bought a new stake in Perrigo during the 4th quarter valued at approximately $2,601,000. Institutional investors and hedge funds own 95.91% of the company’s stock.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Recommended Stories
- Five stocks we like better than Perrigo
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How to Use High Beta Stocks to Maximize Your Investing Profits
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.